Socazolimab Antibody
Socazolimab (ZKAB001) is a humanized PD-L1 monoclonal antibody developed for cancer research. It has demonstrated antitumor activity in preclinical models and is being investigated in clinical studies for recurrent or metastatic cervical cancer.
Product Specifications
Product Name Alternative
STI1014, STI-1014, STIA1014, STI-A1014, ZKA B001, ZKAB001
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
7.4 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.06 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041484-500 1x 500 µL
DOG-1 / TMEM16A (Gastrointestinal Stromal Tumor Marker) (DG1/1484), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC432969 20 µg
FCRLM1 (FCRLA) (NM_001184866) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC473491-500 1x 500 µL
PAI-RBP1 / SERBP1 / SERPINE1 (SERBP1/3491), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 